# Nanophase Technologies Corporation - Inspection Records

Source: https://www.keypedia.com/companies/nanophase-technologies-corporation/2b2b4bbe-7d35-4ece-8a79-dbffc6f82a51

> Inspection records and compliance data for Nanophase Technologies Corporation in Romeoville, Illinois. Access full analysis and detailed observations.

---

## Details

- Name: Nanophase Technologies Corporation
- FEI Number: 3003574860
- City: Romeoville
- State: Illinois
- Country Name: United States
- Address Line 1: 1319 Marquette Dr
- Zip Code: 60446

## Related Documents

- [FDA Inspection 1298600 - Nanophase Technologies Corporation - 2026-01-09](https://www.keypedia.com/records/fda_inspections/nanophase-technologies-corporation/15d88410-e532-46d7-80a1-b982caf658e5) — source: FDA, date: January 9, 2026
- [FDA Inspection 1298600 - Nanophase Technologies Corporation - 2026-01-09](https://www.keypedia.com/records/fda_inspections/nanophase-technologies-corporation/2f9779b0-d2b3-449c-aea2-02771d6ab0b8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 9, 2026
- [483 - Nanophase Technologies Corporation - 2023-04-13](https://www.keypedia.com/records/483/nanophase-technologies-corporation/8272f957-6c93-4953-a84a-545653f7e600) — source: FDA, date: April 13, 2023
- [FDA Inspection 1205286 - Nanophase Technologies Corporation - 2023-04-13](https://www.keypedia.com/records/fda_inspections/nanophase-technologies-corporation/22d2e70e-237e-4e93-9811-df1e87ad4563) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 13, 2023
- [FDA Inspection 1096141 - Nanophase Technologies Corporation - 2019-06-07](https://www.keypedia.com/records/fda_inspections/nanophase-technologies-corporation/395a0561-ea51-4c80-9bb9-b048f6253d4b) — classification: No Action Indicated (NAI), source: FDA, date: June 7, 2019
- [FDA Inspection 896947 - Nanophase Technologies Corporation - 2014-09-15](https://www.keypedia.com/records/fda_inspections/nanophase-technologies-corporation/bc2ad1a6-d733-419b-bfec-fa0c64f23ae2) — classification: No Action Indicated (NAI), source: FDA, date: September 15, 2014
- [FDA Inspection 896947 - Nanophase Technologies Corporation - 2014-09-15](https://www.keypedia.com/records/fda_inspections/nanophase-technologies-corporation/833968bc-ab05-4cad-bf45-9281888fac5f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 15, 2014
- [FDA Inspection 753672 - Nanophase Technologies Corporation - 2011-11-17](https://www.keypedia.com/records/fda_inspections/nanophase-technologies-corporation/7893c76e-eacb-4301-8b5e-92bf0fcd9a48) — classification: No Action Indicated (NAI), source: FDA, date: November 17, 2011
- [FDA Inspection 753672 - Nanophase Technologies Corporation - 2011-11-17](https://www.keypedia.com/records/fda_inspections/nanophase-technologies-corporation/76643ae8-f37f-4efb-a250-39b8f2c615ed) — classification: No Action Indicated (NAI), source: FDA, date: November 17, 2011
- [FDA Inspection 617225 - Nanophase Technologies Corporation - 2009-10-07](https://www.keypedia.com/records/fda_inspections/nanophase-technologies-corporation/25ff6776-b177-4d32-9c68-f01ba129ee5a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 7, 2009
- [FDA Inspection 617225 - Nanophase Technologies Corporation - 2009-10-07](https://www.keypedia.com/records/fda_inspections/nanophase-technologies-corporation/2d830ca1-9ae0-4198-9406-6c641e89848c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 7, 2009

## Related Companies

- [Lupin Limited (Unit 1)](https://www.keypedia.com/companies/lupin-limited-unit-1/92edc845-1756-45db-9f08-e5d611078b5a)
- [Webco Chemical Corp.](https://www.keypedia.com/companies/webco-chemical-corp/91b35090-51c8-4630-a90a-eabe41d0bb4a)
- [Adare Pharmaceuticals, Inc.](https://www.keypedia.com/companies/adare-pharmaceuticals-inc/b1aa5308-ecbd-4a48-adf0-0ed6bd2470c5)
- [Centaur Inc](https://www.keypedia.com/companies/centaur-inc/9106eaba-0e13-420b-a044-e6a6a9eb9459)
- [CSPC Ouyi Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/cspc-ouyi-pharmaceutical-co-ltd/aae55a77-8bde-45fc-a232-7b200c55ea54)
- [Xttrium Laboratories, Inc.](https://www.keypedia.com/companies/xttrium-laboratories-inc/30da7793-2a5c-4bf5-814c-05fc0921d353)
- [Morgan Gallacher, Inc DBA Custom Chemical Formulators Inc.](https://www.keypedia.com/companies/morgan-gallacher-inc-dba-custom-chemical-formulators-inc/cf116ede-f432-4a50-b2ce-47064c96af2c)
- [ACS Dobfar SPA (Plant #2)](https://www.keypedia.com/companies/acs-dobfar-spa-plant-2/334c9ae3-385e-4162-a53a-d53e34111e29)
- [Sage Products, LLC](https://www.keypedia.com/companies/sage-products-llc/0f9d73bb-cc3e-4880-bea8-3496d8fd6397)
- [Regis Technologies, Inc.](https://www.keypedia.com/companies/regis-technologies-inc/b28a19bd-2caa-4023-9b89-ee609c032939)

## Related Officers

- [Peng Zhou](https://www.keypedia.com/people/peng-zhou/ce413ab5-8787-4012-bc8f-9ef55f2c3dc1)